AKT1 and acute lymphoblastic leukemia: The phosphatidylinositiol 3-kinase (PI3K), AKT, and mammalian target of rapamycin (mTOR) (PI3K/AKT/mTOR) is a frequently dysregulated signaling pathway in a wide range of hematological conditions including B- and T-cell ALL.